Deoleo S.A [OLE] vs Naturhouse Health [NTH] Detailed Stock Comparison

Deoleo S.A.

BME
Loading...

Naturhouse Health S.A.U.

BME
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Deoleo S.A. wins in 7 metrics, Naturhouse Health S.A.U. wins in 12 metrics, with 0 ties. Naturhouse Health S.A.U. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Deoleo S.A. Naturhouse Health S.A.U. Better
P/E Ratio (TTM) 16.45 15.00 Naturhouse Health S.A.U.
Price-to-Book Ratio 0.76 8.61 Deoleo S.A.
Debt-to-Equity Ratio 36.99 19.30 Naturhouse Health S.A.U.
PEG Ratio 65.80 17.00 Naturhouse Health S.A.U.
EV/EBITDA 7.39 10.52 Deoleo S.A.
Profit Margin (TTM) 1.15% 21.19% Naturhouse Health S.A.U.
Operating Margin (TTM) 10.83% 23.84% Naturhouse Health S.A.U.
EBITDA Margin (TTM) 10.83% 23.84% Naturhouse Health S.A.U.
Return on Equity 4.65% 40.83% Naturhouse Health S.A.U.
Return on Assets (TTM) 4.47% 21.77% Naturhouse Health S.A.U.
Free Cash Flow (TTM) $8.88M $11.67M Naturhouse Health S.A.U.
Dividend Yield N/A 14.34% N/A
1-Year Return 77.78% 46.24% Deoleo S.A.
Price-to-Sales Ratio (TTM) 0.20 3.21 Deoleo S.A.
Enterprise Value $505.35M $141.84M Deoleo S.A.
EV/Revenue Ratio 0.62 2.98 Deoleo S.A.
Gross Profit Margin (TTM) 54.46% 72.07% Naturhouse Health S.A.U.
Revenue per Share (TTM) $2 $1 Deoleo S.A.
Earnings per Share (Diluted) $0.02 $0.17 Naturhouse Health S.A.U.
Beta (Stock Volatility) 0.71 0.35 Naturhouse Health S.A.U.

Deoleo S.A. vs Naturhouse Health S.A.U. Stock Performance Analysis

Loading Price Chart...

OLE
NTH

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Deoleo S.A.-1.22%0.00%39.13%45.45%68.42%68.42%
Naturhouse Health S.A.U.-0.39%-2.32%-1.56%-5.60%21.05%13.45%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Deoleo S.A.77.78%33.33%-21.95%52.38%-13.51%-13.51%
Naturhouse Health S.A.U.46.24%46.24%51.50%-42.50%-49.30%-49.30%

Performance & Financial Health Analysis: Deoleo S.A. vs Naturhouse Health S.A.U.

MetricOLENTH
Market Information
Market Cap i€164.50M€152.27M
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i3,487,16238,706
90 Day Avg. Volume i2,225,59337,566
Last Close€0.32€2.53
52 Week Range€0.17 - €0.35€1.65 - €2.82
% from 52W High-6.34%-10.28%
All-Time High€0.50 (Nov 25, 2013)€5.69 (Apr 27, 2015)
% from All-Time High-36.00%-55.54%
Growth Metrics
Quarterly Revenue Growth-0.21%-0.01%
Quarterly Earnings Growth0.14%-0.03%
Financial Health
Profit Margin (TTM) i0.01%0.21%
Operating Margin (TTM) i0.11%0.24%
Return on Equity (TTM) i0.05%0.41%
Debt to Equity (MRQ) i36.9919.30
Cash & Liquidity
Book Value per Share (MRQ)€0.44€0.30
Cash per Share (MRQ)€0.07€0.24
Operating Cash Flow (TTM) i€16.80M€12.15M
Levered Free Cash Flow (TTM) i€46.57M€16.12M
Dividends
Last 12-Month Dividend Yield iN/A14.34%
Last 12-Month Dividend i€0.00€0.40

Valuation & Enterprise Metrics Analysis: Deoleo S.A. vs Naturhouse Health S.A.U.

MetricOLE (Apr 24, 2026)NTH (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i16.4515.00
Forward P/E i65.8017.00
PEG Ratio i65.8017.00
Price to Sales (TTM) i0.203.21
Price to Book (MRQ) i0.768.61
Market Capitalization
Market Capitalization i€164.50M€152.27M
Enterprise Value i€505.35M€141.84M
Enterprise Value Metrics
Enterprise to Revenue i0.622.98
Enterprise to EBITDA i7.3910.52
Risk & Other Metrics
Beta i0.710.35
Book Value per Share (MRQ) i€0.44€0.30

Financial Statements Comparison: Deoleo S.A. vs Naturhouse Health S.A.U.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricOLE (2025)NTH (2025)
Revenue/Sales i820.95M47.63M
Cost of Goods Sold i626.25M13.36M
COGS % of Revenue i76.3%28.0%
Gross Profit i194.70M34.27M
Gross Margin i23.7%72.0%
Research & Development iN/AN/A
Operating Income (EBIT) i36.65M13.24M
Operating Margin i4.5%27.8%
EBITDA i41.56M14.74M
EBITDA Margin i5.1%31.0%
Pre-Tax Income i30.59M13.70M
Pre-Tax Income % of Revenue i3.7%28.8%
Income Tax i10.89M3.60M
Income Tax % of Revenue i1.3%7.6%
Net Income (Profit) i19.70M10.09M
Profit Margin i2.4%21.2%

Balance Sheet & Liquidity Metrics

MetricOLE (2025)NTH (2025)
Cash & Equivalents i5.43M13.43M
Total Current Assets i231.56M19.59M
Total Current Assets % of Revenue i28.2%41.1%
Total Current Liabilities i126.33M11.88M
Total Current Liabilities % of Revenue i15.4%24.9%
Long-Term Debt i119.86M1.90M
Long-Term Debt % of Revenue i14.6%4.0%
Total Shareholders Equity i431.26M17.76M
Retained Earnings i204.98M10.09M
Retained Earnings % of Revenue i25.0%21.2%
Property, Plant & Equipment i65.84M0

Cash Flow Statement Comparison

MetricOLE (2025)NTH (2025)
Operating Cash Flow i75.46M14.00M
Operating Cash Flow % of Revenue i9.2%29.4%
Capital Expenditures i-7.07M246,000
Free Cash Flow i8.88M11.67M
FCF Margin i1.1%24.5%
Debt Repayment i-200.17M-953,000
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricOLENTH
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i500.00M59.95M
Float Shares i189.40M13.00M
% Held by Insiders i5.13%78.55%
% Held by Institutions i57.01%0.97%
% Held by Public i37.86%20.48%

Dividend Analysis & Yield Comparison: Deoleo S.A. vs Naturhouse Health S.A.U.

MetricOLENTH
Last 12-Month Dividend i€0.00€0.40
Last 12-Month Dividend Yield iN/A14.34%
3-Year Avg Annual Dividend i€0.00€0.23
3-Year Avg Dividend Yield iN/A4.09%
3-Year Total Dividends i€0.00€0.70
Ex-Dividend DateN/AJan 30, 2026